Predicting Adherence and Persistence with Oral Bisphosphonate Therapy in an Integrated Health Care Delivery System

BACKGROUND: Examining drug exposure is essential to pharmacovigilance, especially for bisphosphonate (BP) therapy. OBJECTIVE: To examine differences in 4 measures of oral BP exposure: treatment discontinuation, adherence, persistence, and nonpersistence. METHODS: Among women aged ≥ 50 years who init...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Manag Care Spec Pharm
Main Authors: Hui, Rita L., Adams, Annette L., Niu, Fang, Ettinger, Bruce, Yi, David K., Chandra, Malini, Lo, Joan C.
Formato: Artigo
Idioma:Inglês
Publicado: Academy of Managed Care Pharmacy 2017
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5641482/
https://ncbi.nlm.nih.gov/pubmed/28345435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18553/jmcp.2017.23.4.503
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares